Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

C-reactive protein evaluation in community-acquired pneumonia with comorbid chronic heart failure as criterion of antibiotic prescription...

Бобyлев А. А., Рачина С. А., Авдеев С. Н., Козлов Р. С., Младов В. В.
Кардиология
Т. 59, С. 40-46
Опубликовано: 2019
Тип ресурса: Статья

DOI:10.18087/cardio.2661

Аннотация:
Aim. To prove that diagnostic algorithm based on additional measurement of serum C-reactive protein (CRP) for administration of systemic antibacterial therapy (ABT) to patients with suspected community-acquired pneumonia (CAP) and concomitant chronic heart failure (CHF) does not influence outcomes of disease. Materials and methods. This open, single-center, randomized, prospective, non-inferiority study included 160 adult patients with documented functional class II–IV CHF who had been admitted with a preliminary diagnosis of non-severe CAP. Patients were randomized at 1:1 to two groups; group 1 – with additional measurement of CRP (n=80) and group 2 – with the use of routine diagnostic methods (n=80). In group 1, systemic ABT was administered only when serum CRP was >28.5 mg/l (threshold level of the biomarker calculated at the previous stage of the study); group 2 received a standard treatment. Non-inferiority test result for both algorithms was evaluated by the number of patients wi
Ключевые слова:
Biomarkers; C-reactive protein; Chronic heart failure; Community-acquired pneumonia
antiinfective agent; C reactive protein; controlled study; heart failure; human; pneumonia; prospective study; randomized controlled trial; Anti-Bacterial Agents; C-Reactive Protein; Heart Failure; Humans; Pneumonia; Prospective Studies
Язык текста: Русский
ISSN: 0022-9040
Бобyлев А. А.
Рачина С. А. Светлана Александровна 1974-
Авдеев С. Н. Сергей Николаевич 1968-
Козлов Р. С.
Младов В. В.
Bobylev A. A.
Rachina S. A. Svetlana Aleksandrovna 1974-
Avdeev S. N. Sergej Nikolaevich 1968-
Kozlov R. S.
Mladov V. V.
C-reactive protein evaluation in community-acquired pneumonia with comorbid chronic heart failure as criterion of antibiotic prescription [Определение C-реактивного белка при внебольничной пневмонии на фоне хронической сердечной недостаточности как критерий назначения антибактериальной терапии]
C-reactive protein evaluation in community-acquired pneumonia with comorbid chronic heart failure as criterion of antibiotic prescription...
Текст визуальный непосредственный
Кардиология
Общество специалистов по сердечной недостаточности
Т. 59 С. 40-46
2019
Статья
Biomarkers C-reactive protein Chronic heart failure Community-acquired pneumonia
antiinfective agent C reactive protein controlled study heart failure human pneumonia prospective study randomized controlled trial Anti-Bacterial Agents C-Reactive Protein Heart Failure Humans Pneumonia Prospective Studies
Aim. To prove that diagnostic algorithm based on additional measurement of serum C-reactive protein (CRP) for administration of systemic antibacterial therapy (ABT) to patients with suspected community-acquired pneumonia (CAP) and concomitant chronic heart failure (CHF) does not influence outcomes of disease. Materials and methods. This open, single-center, randomized, prospective, non-inferiority study included 160 adult patients with documented functional class II–IV CHF who had been admitted with a preliminary diagnosis of non-severe CAP. Patients were randomized at 1:1 to two groups; group 1 – with additional measurement of CRP (n=80) and group 2 – with the use of routine diagnostic methods (n=80). In group 1, systemic ABT was administered only when serum CRP was >28.5 mg/l (threshold level of the biomarker calculated at the previous stage of the study); group 2 received a standard treatment. Non-inferiority test result for both algorithms was evaluated by the number of patients wi